DNA jolt for wrinkles? new trial tests PIEZO-101
Disease control
Not yet recruiting
This early study tests a new treatment called PIEZO-101, a DNA-based biostimulator, for skin aging in the knee and décolleté areas. It is given by injection followed by a mild electric pulse (electroporation) to help it enter skin cells. The trial will enroll 8 healthy women aged…
Phase: EARLY_PHASE1 • Sponsor: Piezo Therapeutics, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC